Forest Labs (FRX) Cuts FY13 Outlook Amid 'Evolving Conditions in the Lexapro/escitalopram Market
Go back to Forest Labs (FRX) Cuts FY13 Outlook Amid 'Evolving Conditions in the Lexapro/escitalopram MarketForest Laboratories (NYSE: FRX) | Delayed: 12.00 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $12.00 | 52 Week High | $100.88 | |||
Open | $24.87 | 52 Week Low | $64.33 | |||
Day High | $12.00 | P/E | 20.69 | |||
Day Low | $12.00 | EPS | $0.58 | |||
Volume | 20 |